Real World Evidence Lead Endo-Metabolic, Global Rare Diseases

4 giorni fa

roma, provincia di roma, Italia Chiesi Tempo pieno



About us
Chiesi is an international research-focused biopharmaceutical group with 90 years' experience, operating in more than 30 countries, with its Headquarter in Parma, Italy. More than 8,000 employees across the group are united by a singular purpose: promoting a healthier world for our people, patients, and the planet. This is what drives us as we research, develop, and market innovative drugs across our main therapeutic areas. Discover more here.

At Chiesi we are thinking generations ahead, driving sustainable innovation with purpose. This fosters a culture of reliability, transparency, and ethical behaviour at every level. As a Benefit Corporation and a certified B Corp, we have embedded sustainability in our bylaws and continuously measure our impact. Diversity and inclusion are at the heart of who we are. We believe our differences make us stronger. We are a vibrant ecosystem of passionate, talented individuals united by strong values, each bringing unique perspectives that help us to continuously challenge the status quo for the better.

Chiesi Global Rare DiseasesChiesi Global Rare Diseases is a Chiesi Group's business unit established in February 2020 and focused on research, development and commercialization of treatments and patient support services for rare and ultra-rare disorders, many of whom have limited or no treatments available. This unit is based in Boston, Massachusetts, with a strong synergy with the headquarters in Parma. Rare unit has a focus on research and product development for lysosomal storage diseases, rare hematology, ophthalmology disorders and rare immunodeficiencies. The unit is also a dedicated partner with global leaders in scientific research, patient advocacy and care. Discover more here.

What we are looking forThis is what you will doReporting to the VP, RWE, the Real World Evidence Lead Endocrine-Metabolic (Endo-Met) is responsible for leading and executing the global RWE strategy and vision for the Endo-Met Portfolio within GRD.
The role ensures the strategy, creation and updating of the integrated evidence generation plan (IEGP), in alignment with cross-functional partners to meet research and commercial objectives. The role drives enterprise-level RWE impact, including building strategic data partnerships, advancing innovative methodologies, and influencing cross-functional decision-making.

You will be responsible forRWE Strategy & LeadershipAct as a change agent, effectively communicating the value of RWE and influencing adoption of new processes and approaches. This includes: Lead the global RWE strategy for the Endo-Met GRD portfolio, acting as the strategic RWE leader across development, regulatory, and commercialization phases, and ensuring its integration into regulatory, payer, and clinical decision-making across the Endo-Metabolic Portfolio including Myalepta (metreleptin) in Lipodystrophy, Juxtapid / Lojuxta (lomitapide) in Homozygous Familial Hypercholesterolemia (HoFH) and future pipeline or acquired assets. Increase the integration of RWD sources to enhance evidence-based decision making through research programs, while providing medical leadership as appropriate on cross-functional teams supporting local and global needs in a prioritized manner.

Publish, where appropriate in high impact journals.

Capability Building & Organizational LeadershipContinuously improve RWE capabilities, processes, and infrastructure to support global and local evidence generation for HIDO Build and scale RWE capabilities as a competitive advantage for GRDEstablish best practices, standards, and ways of working across regionsLead change management to embed RWE into core organizational processesExternal Data & Partnership StrategyLead identification, evaluation, and execution of external RWD partnerships and data acquisition strategiesOversee due diligence, contracting support, and governance of external data sources and collaborationsBuild long-term strategic relationships with academic institutions, data vendors, consortia, and healthcare systemsScientific & Technical LeadershipFoster the appropriate use and adoption of appropriate analytic technologies to improve RWE reliability and applicability to provide insights that matter to internal and external stakeholdersProvide senior scientific leadership and deep technical expertise in observational research, epidemiology, and RWE methodologiesGuide study design, analytics strategy, and interpretation of evidenceEnsure adoption of innovative approaches, including AI/ML and advanced analytics, in RWE generationCross-Functional Influence & IntegrationAct as the RWE subject matter expert within cross-functional teams (Medical, Clinical Development, Market Access, Regulatory)Influence asset strategies, development plans, and access strategiesLead alignment of RWE priorities across global and regional stakeholdersEvidence Generation OversightProvide executive oversight of